Connect with us

News

Ambulatory Electronic Health Record Market Worldwide Growth, Trends, Development Strategy Forecast till 2026

gbafNews28

The Global Ambulatory Electronic Health Record Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Ambulatory Electronic Health Record Market Size, Share and Global Trend By Delivery (Cloud-Based Solutions, On-Premise Solutions, Web-Based Solutions), By Function (Reporting, Planning, Billing, Analysis, Remote Medicine Engagement, Medical Assistance, Others), By End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others) and Geography Forecast till 2026.

Browse Complete Report Details:

https://www.fortunebusinessinsights.com/industry-reports/ambulatory-electronic-health-record-market-100620

Top Key Players Covered:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Ambulatory Electronic Health Record market. Some of the companies operating the global Ambulatory Electronic Health Record market are;

Some of the Main Key Players Covered in the Report

  • WebPT
  • Marshfield Clinic
  • Harris Healthcare
  • Epic Systems Corporation
  • Empowersystems
  • eClinicalWorks
  • CoCENTRIX
  • CGI
  • DSS Imagetech Pvt Ltd
  • Cerner Corporation
  • McKesson Corporation
  • Infor
  • AdhereTech
  • Allscripts
  • Athenahealth
  • Siemens
  • IBM
  • Microsoft
  • Philips
  • NVIDIA
  • Amazing Charts
  • Athenahealth

Rapid adoption of digitalization among practitioners and patients is likely to fuel the demand in the global Ambulatory Electronic Health Record market. Additionally, increasing per capita income and rising living standards is expected to drive the global Ambulatory Electronic Health Record market during the forecast period 2018-2025.

However, high cost associated with the devices and lack of skilled professional to operate the system are a few factors that may hamper the growth in the global Ambulatory Electronic Health Record market.

Request Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/ambulatory-electronic-health-record-market-100620

In-Depth Regional Analysis:

Geographically, the global ambulatory electronic health record (EHR) market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominated the global ambulatory EHR market in 2017 owing to the integration of advanced computing applications and precise healthcare knowledge, rise in workload on hospital processes due to rise in prevalence of chronic diseases, and aging population.

As stated in the report North America holds a significant share in the market. The trend is unlikely to change and North America may continue holding its position. The growth witnessed is attributable to high presence of key developers in nations such as Canada and U.S.

The Asia Pacific Ambulatory Electronic Health Record market is expected to expand at a promising CAGR during the forecast period. The constantly improving healthcare infrastructure in the region is expected to contribute to Asia Pacific market expansion.

The analysis conducted in the report is based on industry leading tools and techniques. The report prepared by Fortune Business Insights, offers innovative strategies based on various analysis. The information offered is collected from reliable primary and secondary sources. The report also provides information about key companies operating in the market.

Key Segmentation:

By Delivery:

  • Cloud-Based Solutions
  • On-Premise Solutions
  • Web-Based Solutions

By Geography:

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (South Africa, GCC, and Rest of the Middle East and Africa)

Major Table of Content For Ambulatory Electronic Health Record Market:

  1. Introduction
  2. Executive Summary
  3. Market Dynamics
  4. Key Insights
  5. Global Ambulatory Electronic Health Record Market Analysis, Insights and Forecast
  6. North America Ambulatory Electronic Health Record Market Analysis, Insights and Forecast
  7. Europe Ambulatory Electronic Health Record Market Analysis, Insights and Forecast
  8. Asia Pacific Ambulatory Electronic Health Record Market Analysis, Insights and Forecast
  9. Middle East and Africa Ambulatory Electronic Health Record Market Analysis, Insights and Forecast
  10. Latin America Ambulatory Electronic Health Record Market Analysis, Insights and Forecast

More Trending Topics from Future Business Insights:

Cardiovascular Stents Market 2019 Global Leading Players, Industry Updates, Growth, Business Prospects, and Future Investments by Forecast to 2025

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]

News

4D Molecular Therapeutics Strengthens Leadership Team with Key Appointments in Clinical Research and Development

gbafNews28

4D Molecular Therapeutics (4DMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced that Robert Fishman, M.D. has joined as Chief Medical Officer & Therapeutic Area Head, Pulmonology; Raphael Schiffmann, M.D. has joined as Senior Vice President & Therapeutic Area Head, Cardiology; and Robert Kim, M.D., M.B.A. has joined as Senior Vice President & Clinical Therapeutic Area Head, Ophthalmology.

4DMT has made tremendous progress since the close of our Series C financing. We have advanced product candidates across our key therapeutic areas of ophthalmology, cardiology and pulmonology, including the initiation of the clinical programs for 4D-110 and 4D-125 in ophthalmology, and 4D-310 for the treatment of Fabry disease, said David Kirn, M.D., co-founder and chief executive officer of 4DMT. With the addition of Robert Fishman, Raphael Schiffmann and Robert Kim to our clinical R&D leadership team, 4DMT gains not only extensive experience in clinical development and translational medicine, but also unique and specific experience within each of the initial 4DMT therapeutic areas. We are thrilled to welcome these respected leaders to 4DMT.

Dr. Robert Fishman has over 20 years of experience in product development including both medicines and aerosol-based drug/device combinations. Dr. Fishman was most recently Chief Medical Officer at Xoc Pharmaceuticals, where he led Phase 1 development of drugs for prevention of migraine and treatment of Parkinsons disease, and prior to that, at Corcept Pharmaceuticals, a publicly traded biopharmaceutical company. Previously, he was Senior Vice President, Clinical Development, at InterMune (acquired by Roche), where he led the final pivotal trial of pirfenidone (Esbriet) for the treatment of idiopathic pulmonary fibrosis. Before that, at Alexza Pharmaceuticals, he led the Phase 3 studies of inhaled loxapine (ADASUVE), a drug/device combination for the rapid treatment of agitation associated with schizophrenia or bipolar I disorder. Dr. Fishman trained in internal medicine at Deaconess Hospital, Boston, completed a fellowship in pulmonary and critical care medicine at Massachusetts General Hospital, and began his career as a member of the Stanford University pulmonary medicine faculty. He serves as a teaching attending physician in the Stanford pulmonary fellows clinic at Palo Alto Veterans Administration Medical Center, and as an advisor to the Stanford SPARK Program in Translational Research. He received an A.B. in Biology from Harvard University and an M.D. from Stanford University School of Medicine.

Dr. Raphael Schiffmann has over 30 years of experience in clinical research, including as an expert on neurometabolic diseases, focusing his research efforts on lysosomal storage disorders. Dr. Schiffmanns writings include 275 peer-reviewed publications in scholarly journals, and 19 book chapters and reviews. Prior to joining 4DMT, he was the Director of the Institute of Metabolic Disease at the Baylor Research Institute. Before that, Dr. Schiffmann was the lead investigator in the Developmental and Metabolic Neurology Branch at the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH). Dr. Schiffmann has an M.D. degree from the University of Li¨ge, Belgium and a degree of Master of Health Sciences in Clinical Research from Duke University. He is Board Certified in pediatrics and in child neurology and is a Fellow of the American Academy of Neurology.

Dr. Robert Kim has over 20 years of product development experience in ophthalmology. Prior to joining 4DMT, Robert was Chief Medical Officer at Viewpoint Therapeutics, where he led translational development efforts for α-crystallin pharmacologic chaperones. Prior to Viewpoint, he was Chief Medical Officer at Apellis Pharmaceuticals and Vision Medicines. Earlier in his career, Robert was Vice President and Head of Pharmaceutical Product Development at Novartis/Alcon and Vice President of Clinical Ophthalmology at GSK. Dr. Kim began his career in drug development at Genentech, where he managed the Lucentis Phase 3 clinical program through to its first product approval in wet age-related macular degeneration. Dr. Kim received his undergraduate and M.D. degrees from Brown University. Dr. Kim completed his residency in ophthalmology at the University of California, San Francisco (UCSF), post-doctoral training in molecular biology at the National Eye Institute, and retina fellowship training at Moorfields Eye Hospital in London before joining the faculty at UCSF. Dr. Kim also holds an M.B.A. from the Haas School of Business at the University of California, Berkeley.

About 4DMT

4DMT is a clinical-stage gene therapy company pioneering the development of product candidates using targeted and evolved AAV vectors. 4DMT seeks to unlock the full potential of gene therapy using its platform, Therapeutic Vector Evolution, which combines the power of directed evolution with approximately one billion synthetic capsid sequences to invent evolved vectors for use in targeted gene therapy products. The company is initially focused in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The 4DMT targeted and evolved vectors are invented with the goal of being delivered through clinically routine, well-tolerated and minimally invasive routes of administration, transducing diseased cells in target tissues efficiently, having reduced immunogenicity and, where relevant, having resistance to pre-existing antibodies. 4DMT is currently conducting three clinical trials: 4D-125 is in a Phase 1/2 clinical trial for XLRP, 4D-110 is in a Phase 1 clinical trial for choroideremia and 4D-310 is in a Phase 1/2 clinical trial for Fabry disease.

4D Molecular Therapeutics„¢, 4DMT„¢, Therapeutic Vector Evolution„¢, and the 4DMT logo are trademarks of 4DMT.

Media:

Theresa Janke

[email protected]

415-321-9396

Investors:

Mike Zanoni

Endurance Advisors

[email protected]

610-442-8570

Continue Reading

News

Pioneer Natural Resources Releases 2020 Sustainability Report, Incorporates Emission Reduction Targets

gbafNews28

Pioneer Natural Resources Company (NYSE:PXD) (Pioneer or the Company) today announced the publication of its 2020 Sustainability Report, detailing the Companys dedication and focus on environmental, social and governance (ESG) programs. The report highlights enhanced disclosures on air emissions, health and safety metrics, diversity and inclusion initiatives, community engagement, board governance and additional detail on the steps Pioneer will take to integrate the assets from the pending acquisition of Parsley Energy into alignment with the Companys announced goals and targets. Pioneers 2020 Sustainability Report is available at www.pxd.com/sustainability.

Highlights from Pioneers 2020 Sustainability Report include:

  • Incorporating greenhouse gas (GHG) and methane emission intensity reduction targets “ Pioneer is formally adopting targets to reduce GHG and methane emission intensities from the Companys operations, including a 25% reduction in GHG intensity and 40% reduction in methane intensity by 2030, inclusive of Parsleys assets. The Companys emission intensity reduction targets are aligned with the Task Force on Climate-related Financial Disclosures (TCFD) criteria for target setting.
  • Continuing leadership position through minimizing flaring “ Establishing a goal to limit the Companys flaring intensity to less than 1% of natural gas produced, with a plan to incorporate Parsleys assets into this target by 2022. In addition, Pioneer will end routine flaring (as defined by the World Bank) by 2030, with the aspiration to accomplish this by 2025.
  • Nearing completion of the Midland Water Project “ A unique infrastructure project where Pioneer invested in upgrading the City of Midlands wastewater treatment plant and in return will receive non-potable water from the City of Midland. This source of treated municipal wastewater will displace freshwater used in the Companys operations and represent a significant milestone in Pioneers ongoing freshwater reduction strategy.
  • Increasing health, safety and environment (HSE) and ESG goal weighting in executive compensation “ Demonstrating Pioneers focus on both HSE and ESG strategies and metrics, the Companys Board of Directors has increased the executive incentive compensation weighting of HSE and ESG goals from 10% to 20%, beginning in 2021.

President and CEO Scott D. Sheffield stated, Pioneer continues to make our comprehensive ESG and HSE strategies a top priority. With this report, we are pleased to announce the improvements we have made over the past year as well as additional environmental targets, including the adoption of greenhouse gas and methane emission reduction targets, continuing our leadership through minimizing flaring and progressing projects that reduce our freshwater usage. Our pending acquisition of Parsley combines similar values with a shared commitment to environmental stewardship. Pioneer has a bright future supplying low-cost energy to the world while adhering to the highest ESG standards.

Chairman of the Board, J. Kenneth Thompson, stated, The Boards engagement in ESG and climate-related concerns is a top priority. We are increasing the weighting of these metrics in executive incentive compensation from 10% to 20% beginning in 2021 and continue to enhance Board governance on ESG and HSE initiatives to ensure Pioneers leadership position continues into the future. While Board engagement is important, execution on the ground is critical to achieving our goals outlined in this report. The high standards in which our employees perform their work translates into a focus on safety, a commitment to environmental excellence and a culture that promotes strong social values.

Additional information on Pioneers strategy and performance on ESG and HSE initiatives can be found in the report accessible on the Companys website listed above. The Company announced its plan to implement the principles of the TCFD in its sustainability reporting. This years report references the following reporting standards, terminology and performance metrics: TCFD, Global Reporting Initiative (GRI), International Petroleum Industry Environmental Conservation Association (IPIECA), Carbon Disclosure Standards Board (CDSB), Sustainability Accounting Standards Board (SASB) for oil and gas exploration and production standards and the United Nations Sustainable Development Goals (SDGs).

Pioneer is a large independent oil and gas exploration and production company, headquartered in Dallas, Texas, with operations in the United States. For more information, visit Pioneers website at www.pxd.com.

Additional Information and Where to Find It

This communication may be deemed to be solicitation material in respect of the proposed transaction between Pioneer Natural Resources Company (Pioneer) and Parsley Energy, Inc. (Parsley). The proposed transaction will be submitted to Pioneers stockholders and Parsleys stockholders for their consideration. Pioneer and Parsley have filed a joint proxy statement/prospectus (the Joint Proxy Statement/Prospectus) with the Securities and Exchange Commission (the SEC) in connection with the solicitation of proxies by Pioneer and Parsley in connection with the proposed transaction. Pioneer has filed a registration statement on Form S-4 (the Form S-4) with the SEC, in which the Joint Proxy Statement/Prospectus was included. The information in the Form S-4 is not complete and may be changed. Pioneer and Parsley also intend to file other relevant documents with the SEC regarding the proposed transaction. After the Form S-4 is declared effective by the SEC, the definitive Joint Proxy Statement/Prospectus will be mailed to Pioneers stockholders and Parsleys stockholders. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE PROPOSED TRANSACTION, INVESTORS AND STOCKHOLDERS OF PIONEER AND INVESTORS AND STOCKHOLDERS OF PARSLEY ARE URGED TO READ THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY DO AND WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

The Joint Proxy Statement/Prospectus, any amendments or supplements thereto and other relevant materials, and any other documents filed by Pioneer or Parsley with the SEC, may be obtained once such documents are filed with the SEC free of charge at the SECs website at www.sec.gov or free of charge from Pioneer at www.pxd.com or by directing a request to Pioneers Investor Relations Department at [email protected] or free of charge from Parsley at www.parsleyenergy.com or by directing a request to Parsleys Investor Relations Department at [email protected].

No Offer or Solicitation

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

Participants in the Solicitation

Pioneer, Parsley and certain of their respective executive officers, directors, other members of management and employees may, under the rules of the SEC, be deemed to be participants in the solicitation of proxies in connection with the proposed transaction. Information regarding Pioneers directors and executive officers is available in its Proxy Statement on Schedule 14A for its 2020 Annual Meeting of Stockholders, filed with the SEC on April 9, 2020 and in its Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on February 24, 2020. Information regarding Parsleys directors and executive officers is available in its Proxy Statement on Schedule 14A for its 2020 Annual Meeting of Stockholders, filed with the SEC on April 6, 2020 and in its Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC on February 21, 2020. These documents may be obtained free of charge from the sources indicated above. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, is and will be contained in the Form S-4, the Joint Proxy Statement/Prospectus and other relevant materials relating to the proposed transaction to be filed with the SEC. Stockholders and other investors should read the Joint Proxy Statement/Prospectus carefully before making any voting or investment decisions.

Cautionary Statement Regarding Forward-Looking Information

Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements and the business prospects of Pioneer are subject to a number of risks and uncertainties that may cause Pioneers actual results in future periods to differ materially from the forward-looking statements. These risks and uncertainties include, among other things, volatility of commodity prices, product supply and demand; the impact of a widespread outbreak of an illness, such as the COVID-19 pandemic, on global and U.S. economic activity; competition; the ability to obtain environmental and other permits and the timing thereof; other government regulation or action; the ability to obtain approvals from third parties and negotiate agreements with third parties on mutually acceptable terms; litigation; the costs and results of drilling and operations; availability of equipment, services, resources and personnel required to perform the Companys drilling and operating activities; access to and availability of transportation, processing, fractionation, refining, storage and export facilities; Pioneer’s ability to replace reserves; implement its business plans or complete its development activities as scheduled; access to and cost of capital; the financial strength of counterparties to Pioneer’s credit facility, investment instruments and derivative contracts and purchasers of Pioneer’s oil, natural gas liquids and gas production; uncertainties about estimates of reserves and resource potential; identification of drilling locations and the ability to add proved reserves in the future; the assumptions underlying forecasts, including forecasts of production, cash flow, well costs, capital expenditures, rates of return, expenses, and cash flow from purchases and sales of oil and gas, net of firm transportation commitments; sources of funding; tax rates; quality of technical data; environmental and weather risks, including the possible impacts of climate change; cybersecurity risks; ability to implement stock repurchases; the risks associated with the ownership and operation of the Company’s oilfield services businesses and acts of war or terrorism. These and other risks are described in Pioneer’s Annual Report on Form 10-K for the year ended December 31, 2019, Quarterly Reports on Form 10-Q filed thereafter and other filings with the United States Securities and Exchange Commission. In addition, the Company may be subject to currently unforeseen risks that may have a materially adverse effect on it.

Additionally, the information in this news release contains forward-looking statements related to the recently announced merger transaction between the Company and Parsley. Such forward-looking statements are subject to risks and uncertainties that are difficult to predict and, in many cases, beyond the Company’s control. These risks and uncertainties include, among other things, the risk that the businesses of Pioneer and Parsley will not be integrated successfully; the cost savings, synergies and growth from the proposed transaction may not be fully realized or may take longer to realize than expected; management time may be diverted on transaction-related issues; the potential adverse effect of future regulatory or legislative actions on Pioneer and Parsley or the industries in which they operate, including the risk of new restrictions with respect to development activities on Pioneer’s or Parsley’s assets; the credit ratings of the combined company or its subsidiaries may be different from what Pioneer expects; Pioneer or Parsley may be unable to obtain governmental and regulatory approvals required for the proposed transaction, or that required governmental and regulatory approvals may delay the proposed transaction or result in the imposition of conditions that could reduce the anticipated benefits from the proposed transaction or cause the parties to abandon the proposed transaction; a condition to closing of the proposed transaction may not be satisfied; the length of time necessary to consummate the proposed transaction may be longer than anticipated for various reasons; potential liability resulting from pending or future litigation related to the proposed transaction; the potential impact of the announcement or consummation of the proposed transaction on relationships with customers, suppliers, and competitors; and transaction costs may be higher than anticipated.

Accordingly, no assurances can be given that the actual events and results will not be materially different than the anticipated results described in the forward-looking statements. Pioneer undertakes no duty to publicly update these statements except as required by law.

Pioneer Natural Resources Company Contacts:

Investors

Neal Shah – 972-969-3900

Tom Fitter – 972-969-1821

Michael McNamara – 972-969-3592

Greg Wright – 972-969-1770

Media and Public Affairs

Tadd Owens – 972-969-5760

Christina Voss – 972-969-5706

Continue Reading

News

Okta Secures the Identities of Banks, Accelerating Digital Transformation in Financial Services

gbafNews28

Okta, Inc. (NASDAQ:OKTA), the leading independent provider of identity for the enterprise, today announced significant momentum in the financial services industry with new and expanded deployments for Canadian Western Bank, First National of Nebraska, and Nota, powered by M&T Bank. Okta also announced financial results for its third fiscal quarter of FY21, as well as new global customers and expanded partnerships including Fortune 500 IT services company DXC Technology, Finance of America, OFX, Renault, State of Iowa, Washington State Board of Community and Technical Colleges, and Zoom.

Every organization is becoming a technology company as they digitally transform to adapt to changes in consumer expectations and evolving workforce needs. As a result, companies of all sizes and across industries including financial services are investing in the technologies to streamline processes, reduce costs, secure their people and information, and improve customer experiences to drive business growth, said Todd McKinnon, Chief Executive Officer and co-founder, Okta. At Okta, were committed to supporting financial services organizations of all sizes to make this shift, while ensuring trust across the board the experience needs to be seamless, and critical financial information needs to remain secure.

For many financial services organizations, trust is essential to attracting and retaining customers. According to recent research, more than 55% of customers that opened an account with a financial institution did so because they trust that organization.

Canadian Western Bank

Canadian Western Bank is the seventh largest publicly traded bank in Canada with 43 branch locations and over 2,500 employees, serving tens of thousands of clients with a special focus on business owners. On a mission to digitally transform, the organization deployed Oktas Workforce Identity products including Okta Universal Directory, Lifecycle Management, Single Sign-on, and Multi Factor Authentication, to protect its employees, improve user experience, and drive growth across branch locations. The bank also has plans to roll out Okta Access Gateway in support of its ongoing hybrid strategy.

Following a successful rollout of the Okta Identity Cloud across its workforce, Canadian Western Bank decided to expand its deployment to include Okta Customer Identity and to support its goal of creating a consistent customer experience across all lines of business. With Okta as the single entry point to Canadian Western Banks digital experience, the organization will be able to ensure each customer has a highly personalized and simple experience.

At Canadian Western Bank, we take a personalized and proactive approach to banking so we can provide customers with the right financial solutions, said Cory Gould, Chief Information Security Officer, Canadian Western Bank. In order to be successful in this approach, its critical that we have the right technologies in place. This is the driving force for our digital transformation. Okta has been a critical component of this transformation and were excited about the quality of employee experiences were able to deliver with Okta at the core.

First National of Nebraska

First National of Nebraska is one of the largest privately owned banks in the U.S. with 6 million customers and 5,000 employees. The bank originally deployed the Okta Identity Cloud to secure its workforce in 2018, leveraging Okta Lifecycle Management, Single Sign-on, and Multi Factor Authentication to redefine its security posture and reduce IT friction. With the Okta Identity Cloud, First National of Nebraska can seamlessly manage the identities of its employees across various stages of employment.

After this initial success, the First National of Nebraska team decided to expand its use of the Okta Identity Cloud to replace its legacy customer identity solution and power identity for its new customer-facing application and website, providing the banks customers with smooth, secure online access to their banking information. With Okta, First National of Nebraska can take a granular approach to providing access to customers based on various criteria across its family of banks.

As Okta continues to launch new products, First National of Nebraska has plans to expand its use of the Okta Identity Cloud, including the deployment of Okta Advanced Server Access to manage and automate identity and access controls for servers across the cloud and on-premises.

Since the beginning, our customers have remained our priority as weve expanded from a local bank serving the Omaha area to a larger network of banks across multiple states, said Jeff Weeks, SVP and Chief Information Security Officer, First National of Nebraska. As weve evolved, Okta has been critical to providing a seamless user experience for our workforce and customers alike. Were excited to continue our partnership with Okta as they continue to innovate to meet our needs.

Nota

Powered by M&T Bank, a Fortune 500 company, Nota provides digital banking services to help lawyers track and manage client funds. Nota has been cloud-first from its start and recognized the need for a customer identity solution to meet its clients high standards for security and ease of use, while also being simple for the Nota team to implement. After an exhaustive review, Nota selected the Okta Identity Cloud to power the login experience for its clients, primarily due to its robust SDKs, ease of adoption, and industry standard encryption. In one week, Nota was up and running with Okta Customer Identity, providing a trusted entrypoint for its clients to all of their banking needs.

We serve a clientele that requires the highest level of security. With the Okta Identity Cloud at the core of our products and services, our clients have confidence that their financial information is secure, and they can easily take care of their financial needs from anywhere, allowing them to focus on what they do best ““ practicing law, said Paul Garibian, President, Nota. As we continue to grow, were thrilled to have Okta as our partner to ensure we provide the most seamless and secure experience for our clients.

Continued Momentum for Okta

In its third quarter of fiscal year 2021, Okta grew its total customers to 9,400 organizations. This customer growth is part of continued momentum for the company, which includes recent product innovation and announcements. At Oktas annual Showcase event in October, the company announced a partnership and new integration between the Okta Identity Cloud and Salesforce Work.com, advancements to Okta Advanced Server Access, Okta Customer Identity Workflows, new specializations within Okta Partner Connect, and more. In addition, this quarter Okta welcomed Alvina Antar as SVP and CIO, and announced the hiring of Susan St. Ledger as president of worldwide field operations.

About Okta

Okta is the leading independent provider of identity for the enterprise. The Okta Identity Cloud enables organizations to securely connect the right people to the right technologies at the right time. With over 6,500 pre-built integrations to applications and infrastructure providers, Okta customers can easily and securely use the best technologies for their business. More than 9,400 organizations, including JetBlue, Nordstrom, Slack, T-Mobile, Takeda, Teach for America and Twilio, trust Okta to help protect the identities of their workforces and customers.

Jenna Kozel King

[email protected]

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News44 mins ago

Pioneer Natural Resources Releases 2020 Sustainability Report, Incorporates Emission Reduction Targets

Pioneer Natural Resources Company (NYSE:PXD) (Pioneer or the Company) today announced the publication of its 2020 Sustainability Report, detailing the...

gbafNews28 gbafNews28
News44 mins ago

4D Molecular Therapeutics Strengthens Leadership Team with Key Appointments in Clinical Research and Development

4D Molecular Therapeutics (4DMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced...

gbafNews28 gbafNews28
News45 mins ago

Okta Secures the Identities of Banks, Accelerating Digital Transformation in Financial Services

Okta, Inc. (NASDAQ:OKTA), the leading independent provider of identity for the enterprise, today announced significant momentum in the financial services...

gbafNews28 gbafNews28
News47 mins ago

Splunk Inc. Announces Fiscal Third Quarter 2021 Financial Results

Splunk Inc. (NASDAQ: SPLK), provider of the Data-to-Everything Platform, today announced results for its fiscal third quarter ended October 31,...

gbafNews28 gbafNews28
News48 mins ago

Okta Announces Strong Third Quarter Results

Okta, Inc. (NASDAQ: OKTA), the leading independent provider of identity for the enterprise, today announced financial results for its third...

gbafNews28 gbafNews28
News48 mins ago

Snowflake Reports Financial Results for the Third Quarter of Fiscal 2021

Snowflake (NYSE: SNOW), provider of the Data Cloud, today announced financial results for its third quarter of fiscal 2021, ended...

gbafNews28 gbafNews28
News48 mins ago

Washington Prime Group’s Tangible™ Collective Provides a Spotlight for Seven New Brands, Honoring Small Businesses and Local Artisans

When the coronavirus pandemic began in March, businesses of all sizes felt the effects, including empty stadiums and arenas, once...

gbafNews28 gbafNews28
News49 mins ago

Alerus Announces Intent to Acquire Retirement Planning Services, Inc.

Alerus Financial Corporation (Alerus) (NASDAQ: ALRS), announced today it has entered into a definitive agreement to acquire Retirement Planning Services,...

gbafNews28 gbafNews28
News49 mins ago

Sir Andrew Witty Returns to UnitedHealth Group After Leave of Absence

UnitedHealth Group (NYSE: UNH) announced that Sir Andrew Witty, president of UnitedHealth Group and chief executive officer of Optum, has...

gbafNews28 gbafNews28
News49 mins ago

Maximus Named 2020 Grand ClearMark Award Winner for Healthcare Communication

Maximus (NYSE: MMS), a leading provider of government services worldwide, announced today they won five categories in the Center for...